Laboratory screening test with inhalant and food allergens in atopic Brazilian children and adolescents: a performance.

The Phadiatop Infant® (PhInf) is a panel developed to assess allergic sensitization (immunoglobulin E [IgE]) in children aged 13 years having allergy (95%). The PhInf and sIgE agreement between patients (Kappa = 0.94, P 13 years was excellent (Kappa = 0.936, P < 0.001). Compared with sIgE dosage, PhInf had high sensitivity (97%) and specificity (93%). Positivity of PhInf test in this population was high and had an excellent correlation with the allergens comprising the panel. It is a useful method for screening children suspected of having allergic diseases in a non-European country.